Alpha Tau Medical focuses on research, development, and commercialization of Diffusing Alpha-Emitters Radiation Therapy, a new type of brachytherapy for the treatment of solid cancer tumors. By using alpha radiation rather than the commonly used beta or gamma radiation, Alpha Tau Medical’s therapy is more effective than standard brachytherapy methods with less radiation, adverse effects and toxicities. The company is initially focusing on the treatment of head and neck cancer as well as skin and oral cavity cancer and it is currently conducting clinical studies to expand the treatment to additional types of cancer.
- Alpha TAU Medical Ltd.
- Ayala Pharmaceuticals Inc.
- Brainsway Ltd.
- Chemomab Therapeutics Ltd.
- Elbit Vision Systems Ltd.
- Foamix Pharmaceuticals Ltd.
- Galooli Ltd.
- Gamida Cell Ltd.
- Intec Pharma Ltd.
- Kahr Medical Ltd.
- Kamada Ltd.
- Lightricks Ltd.
- Mapi Pharma Ltd.
- MeMed Diagnostics Ltd.
- Polus Tech Pty Ltd.
- PolyPid Ltd.
- ReWalk Robotics Ltd.
- SuperDerivatives Inc.
- Syqe Medical Ltd.
- Tipa Corp. Ltd.
- Trax Ltd.
- Veev
- Yotpo Ltd.
- Other